# FDA Inspection 1031115 - Lancaster General Hospital IRB - August 31, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/lancaster-general-hospital-irb/de392805-763c-480d-8f8d-df786ddc08ad
Source feed: FDA_Inspections

> FDA Inspection 1031115 for Lancaster General Hospital IRB on August 31, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1031115
- Company Name: Lancaster General Hospital IRB
- Inspection Date: 2017-08-31
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 723791 - 2011-05-03](https://www.globalkeysolutions.net/records/fda_inspections/lancaster-general-hospital-irb/1fa71cfb-05b2-4ed6-a4da-4221bb1b01e5)

Company: https://www.globalkeysolutions.net/companies/lancaster-general-hospital-irb/632068dc-5fe4-48e9-9f69-c511684e717a

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c